Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: INOVIQ pops 45pc after revealing breakthrough exosome therapy to kill breast cancer
News
Traders’ Diary: Everything you need to get ready for the week ahead
Health & Biotech
ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System
Health & Biotech
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
Health & Biotech
ASX Health Stocks: Telix says TLX592 shows promise in prostate cancer battle
Health & Biotech
Top ASX biotechs catching the eye of analysts and fund managers in 2024 – Part 1
Health & Biotech
ASX Health Stocks: Island Pharma releases data on dengue fever drug, IDT signs $3m+ deal with Sanofi
News
ASX Small Caps and IPO Weekly Wrap: Gold and medicine are the best medicine
News
Closing Bell: ASX goes missing as new premiums lift health stocks; Bitcoin at US$68k
News
ASX Large Caps: AI craze sweeps ASX; Block Inc, Aussie Broadband up 17pc, Newmont dips 7pc
Health & Biotech
ASX Health Stocks: Cochlear upgrades guidance, Chimeric up 12pc after commencing Phase 1B trial on leukaemia
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Health & Biotech
ASX Health Stocks: US bound Telix plans dual listing on the NASDAQ
News
Market Highlights: Magnificent 7 all at sea in New York as iron ore trades higher
Health & Biotech
ASX Health Stocks: dorsaVi up 27pc on US deals, Starpharma reports positive outcome on Phase 2 trial
Experts